Characterising lipoteichoic acid as an in vitro model of acute neuroinflammation

Anne-Marie Howe1, Aoife Cosgrave1, Maitiú Ó'Murchú1

  • 1UCD School of Biomolecular & Biomedical Science, UCD Conway Institute, University College Dublin, Ireland.

Insights

Toll-like receptor 2 (TLR2) activation by lipoteichoic acid (LTA) triggers acute neuroinflammation and primes neurons for amyloid-beta (Aβ) effects. A TrkB agonist, 7,8,3-trihydroxyflavone (7,8,3-THF), mitigates these inflammatory responses.

Area of Science:

  • Neuroimmunology
  • Microbial Pathogenesis
  • Neuroinflammation

Background:

  • Toll-like receptor 2 (TLR2) senses pathogens and endogenous signals like amyloid-beta (Aβ).
  • TLR2 activation contributes to neuroinflammation, microglial activation, and neuronal dysfunction.
  • Emerging evidence links TLR2 to acute inflammatory disorders such as anxiety and depression.

Purpose of the Study:

  • To characterize acute lipoteichoic acid (LTA) effects on microglial activation and neuronal integrity.
  • To assess LTA's influence on Aβ-induced inflammation and neuronal dysfunction.
  • To investigate the therapeutic potential of 7,8,3-trihydroxyflavone (7,8,3-THF) against LTA-induced neuroinflammation.

Main Methods:

  • In vitro studies using BV2 (microglia) and N2a (neuron) cell lines.
  • Acute hippocampal slice electrophysiology to assess neuronal activity.
  • Treatment with LTA, Aβ, and 7,8,3-THF, a TrkB agonist.

Main Results:

  • Acute LTA exposure induced inflammatory cytokine and nitric oxide (NO) production in both microglia and neurons.
  • LTA exposure enhanced microglial sensitivity to Aβ, promoting an M1-like phenotype and neuronal dysregulation.
  • 7,8,3-THF significantly reduced LTA-induced interleukin-6 (IL-6) and NO production.

Conclusions:

  • Acute TLR2 activation by LTA drives neuroinflammation and primes neuronal sensitivity to Aβ.
  • TLR2 represents a potential therapeutic target for acute neuroinflammatory conditions.
  • Gram-positive bacterial exposure may increase susceptibility to age-related neuroinflammation.